SCM

Stonepine Capital Management Portfolio holdings

AUM $126M
1-Year Est. Return 70.12%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+70.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$123M
AUM Growth
+$21.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
77
New
Increased
Reduced
Closed

Top Buys

1 +$9.75M
2 +$4.83M
3 +$3.92M
4
XFOR icon
X4 Pharmaceuticals
XFOR
+$2.72M
5
ABEO icon
Abeona Therapeutics
ABEO
+$2.57M

Top Sells

1 +$5.23M
2 +$3.09M
3 +$2.52M
4
ENTA icon
Enanta Pharmaceuticals
ENTA
+$2.39M
5
ANIK icon
Anika Therapeutics
ANIK
+$2.02M

Sector Composition

1 Healthcare 99.76%
2 Financials 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUNG icon
26
Pulmonx
LUNG
$65.2M
$1.09M 0.88%
670,000
+524,100
DVAX
27
DELISTED
Dynavax Technologies
DVAX
$1.07M 0.87%
108,094
+78,094
HRTX icon
28
Heron Therapeutics
HRTX
$218M
$1.07M 0.87%
850,100
+192,720
VNDA icon
29
Vanda Pharmaceuticals
VNDA
$527M
$973K 0.79%
195,000
-55,000
VIR icon
30
Vir Biotechnology
VIR
$1.26B
$914K 0.74%
160,000
+30,000
MNKD icon
31
MannKind Corp
MNKD
$1.01B
$846K 0.69%
+157,569
MXCT icon
32
MaxCyte
MXCT
$86.5M
$725K 0.59%
+459,018
ANTX icon
33
AN2 Therapeutics
ANTX
$30.1M
$716K 0.58%
563,913
+19,419
ZNTL icon
34
Zentalis Pharmaceuticals
ZNTL
$155M
$685K 0.56%
453,800
+344,790
ANGO icon
35
AngioDynamics
ANGO
$472M
$670K 0.54%
60,000
-17,141
GRCE
36
Grace Therapeutics
GRCE
$66.4M
$628K 0.51%
211,010
-81,490
RARE icon
37
Ultragenyx Pharmaceutical
RARE
$2.26B
$602K 0.49%
+20,000
SNDX icon
38
Syndax Pharmaceuticals
SNDX
$1.89B
$572K 0.47%
37,200
-55,700
AQST icon
39
Aquestive Therapeutics
AQST
$488M
$562K 0.46%
+100,600
GOSS icon
40
Gossamer Bio
GOSS
$98.3M
$539K 0.44%
+204,770
BOLD
41
Boundless Bio
BOLD
$26M
$509K 0.41%
413,453
+307,278
HCAT icon
42
Health Catalyst
HCAT
$115M
$443K 0.36%
155,551
+55,551
ESTA icon
43
Establishment Labs
ESTA
$2.29B
$434K 0.35%
10,585
+3,585
PLRX icon
44
Pliant Therapeutics
PLRX
$79.9M
$428K 0.35%
+289,237
CTMX icon
45
CytomX Therapeutics
CTMX
$910M
$399K 0.32%
+125,000
KPRX icon
46
Kiora Pharmaceuticals
KPRX
$7.69M
$391K 0.32%
140,598
-37,402
RZLT icon
47
Rezolute
RZLT
$307M
$376K 0.31%
40,000
-179,000
ACRS icon
48
Aclaris Therapeutics
ACRS
$311M
$367K 0.3%
192,900
-298,400
INAB icon
49
IN8bio
INAB
$16.6M
$346K 0.28%
159,421
+76,991
HSDT icon
50
Solana Company
HSDT
$98.7M
$298K 0.24%
+20,000